820 filings
425
ABIO
ARCA biopharma Inc
25 Apr 24
Business combination disclosure
4:27pm
8-K
ABIO
ARCA biopharma Inc
25 Apr 24
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
4:25pm
10-Q
2024 Q1
ABIO
ARCA biopharma Inc
Quarterly report
25 Apr 24
4:15pm
8-K
ABIO
ARCA biopharma Inc
23 Apr 24
Departure of Directors or Certain Officers
4:20pm
8-K
ABIO
ARCA biopharma Inc
4 Apr 24
Departure of Directors or Certain Officers
4:30pm
425
m0iybf1igqh6l4r4zq
3 Apr 24
Business combination disclosure
7:33am
8-K
y9ddp026o8nt
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am
8-K
tmetu3daj 848ihz0mm8
22 Mar 24
Entry into a Material Definitive Agreement
4:20pm
8-K
1d8vks5skybli1n40p38
6 Feb 24
Departure of Directors or Certain Officers
4:15pm
8-K
qk2ed065 d426
1 Feb 24
ARCA biopharma Announces 2023 Financial Results
4:39pm
8-K
8an8tqx
31 Jan 24
Departure of Directors or Certain Officers
4:15pm
ARS
0rl7bsz25f
19 Dec 23
Annual report to shareholders
4:25pm
DEFA14A
achz9ch8l tv8j
19 Dec 23
Additional proxy soliciting materials
4:20pm
8-K
c5ccljgg7760ki7
5 Dec 23
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:25pm
8-K
86ozb
4 Dec 23
Departure of Directors or Certain Officers
4:36pm
8-K
6w73z139
18 Oct 23
ARCA biopharma Announces Third Quarter 2023 Financial Results
4:35pm
8-K
clqte
21 Jul 23
ARCA biopharma Announces Second Quarter 2023 Financial Results
4:35pm